Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)
Clinical trial NCT02947620 · COMPLETED
Trial details
- NCT number
- NCT02947620
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2017-02-27
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.